Preliminary reports suggest conolidine might inhibit certain ion channels, decreasing neuronal excitability and limiting soreness indicators. This mechanism is particularly appropriate in neuropathic agony, wherever irregular signaling brings about persistent distress. Also, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to discomfort perception. C... https://oliverj339nfu5.celticwiki.com/user